Condition: Osteoarthritis Shoulder · Avascular Necrosis · Post-traumatic Arthrosis of Other Joints, Shoulder Region · Sponsor: Stryker Trauma and Extremities
This study is an international, single arm, multicenter, prospective, non-significant risk, Post-Market Clinical Follow-up study, which is designed to collect safety and performance data at baseline, surgery, immediate post-op and annually through 10 years post-operation. Data collected from this study will be used for purposes, including but not limited to, Post-Market Surveillance, peer-reviewed publications, education materials, regulatory submissions, and/or product development.
This description comes directly from the study's public registry record.
Meredith Schreier · 901-232-2704 · meredith.schreier@stryker.com
Amjad Uneisi · amjad.uneisi@stryker.com
Always discuss trial participation with your own doctor first.
| Baptist Healthcare | Lexington, Kentucky, United States | Recruiting |
| Summit Orthopedics | Eagan, Minnesota, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Terminated |
| Washington University | St Louis, Missouri, United States | Active Not Recruiting |
| Orthopedic Institute | Sioux Falls, South Dakota, United States | Recruiting |
| University of Utah | Salt Lake City, Utah, United States | Recruiting |
| Roth McFarlane Hand and Upper Limb Centre | London, Ontario, Canada | Active Not Recruiting |
| Orthopedic Center Santy | Lyon, France | Active Not Recruiting |
| Schulthess Klinik | Zurich, Switzerland | Active Not Recruiting |
| Wrightington Hospital | Wigan, Lancashire, United Kingdom | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05067543